Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A dilated cardiomyopathy that has material basis in variation in the chromosome region 7q22.3-q31.1.
Features include always present findings: Enlarged and weakened heart (dilated cardiomyopathy).
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 1 | Enlarged and weakened heart (dilated cardiomyopathy) |
Biomarker and diagnostic research for dilated cardiomyopathy 1Q has been reported in the published literature.
Phenotype severity distribution: 1 always present feature.
No clinical trials have been registered for dilated cardiomyopathy 1Q.
4 publications have been identified in PubMed for dilated cardiomyopathy 1Q. Research spans Epidemiology / Natural History (50%), Diagnostic / Biomarker (25%), and Basic Science / Preclinical (25%).
van der Have O (2025). [PMID: 40820386](https://pubmed.ncbi.nlm.nih.gov/40820386/). *Pediatr Transplant*. [Epidemiology / Natural History]
Krivec N (2024). [PMID: 39572522](https://pubmed.ncbi.nlm.nih.gov/39572522/). *Cell Death Dis*. [Basic Science / Preclinical]
Amr A (2024). [PMID: 39076310](https://pubmed.ncbi.nlm.nih.gov/39076310/). *Rev Cardiovasc Med*. [Epidemiology / Natural History]
Liu C (2024). [PMID: 39318632](https://pubmed.ncbi.nlm.nih.gov/39318632/). *Front Immunol*. [Diagnostic / Biomarker]
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 4:30 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
AI-curated news mentioning dilated cardiomyopathy 1Q
Updated Aug 3, 2026
A recent study explores the relationship between left ventricular hypertrabeculation and prognosis in dilated cardiomyopathy. Findings suggest that hypertrabeculation may serve as a prognostic marker in patients with this condition.
A new study published in PubMed explores the epidemiology of non-ischaemic dilated cardiomyopathy, providing insights into its prevalence and risk factors. This research contributes to the understanding of this rare heart condition.
A new study evaluates women with peripartum or dilated cardiomyopathy and their first-degree relatives, contributing to the understanding of these conditions. The DCM Precision Medicine Study aims to enhance precision medicine approaches for affected families.